"Fakultná nemocnica s poliklinikou Žilina je treťou najväčšou fakultnou nemocnicou na Slovensku. Strategická poloha a rozsiahla spádová oblasť sa odzrkadľujú v počte, spektre i náročnosti operačných výkonov, vyšetrení, hospitalizácii. Nemocnica prešla v poslednom období radikálnymi zmenami, modernizáciami a naďalej pokračuje v rozvoji kvality a dostupnosti špičkových odborností s dlhodobou tradíciou."

During the past decade, Fakultna Nemocnica S Poliklinikou Zilina conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 8 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fakultna Nemocnica S Poliklinikou Zilina" #1 sponsor was "Pfizer" with 5 trials, followed by "Bayer" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Celgene" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fakultna Nemocnica S Poliklinikou Zilina" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator and "Memorial Sloan Kettering Cancer Center" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Fakultna Nemocnica S Poliklinikou Zilina" are "Depressive Disorder, Major" (2 trials), "Diabetic Retinopathy" (2 trials), "Prostate Cancer" (2 trials), "Bone Metastasis" (1 trials) and "Cancer Pain" (1 trials). Many other conditions were trialed in "Fakultna Nemocnica S Poliklinikou Zilina" in a lesser frequency.

Most popular intervention types in "Fakultna Nemocnica S Poliklinikou Zilina" are "Drug" (18 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Leuprolide" (2 trials), "Ocrelizumab" (2 trials), "Aflibercept" (1 trials) and "Aflibercept 2mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fakultna Nemocnica S Poliklinikou Zilina" are 17 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Fakultna Nemocnica S Poliklinikou Zilina". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Fakultna Nemocnica S Poliklinikou Zilina, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Fakultna Nemocnica S Poliklinikou Zilina, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".